Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2026 14:00 ET | Source: Custom Market Insights

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
March 10, 2026 10:44 ET | Source: PolTREG S.A.

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland,...
March 10, 2026 07:55 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics...
March 10, 2026 07:30 ET | Source: Piston Bio

Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy

MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the...
March 10, 2026 02:30 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics confirme Marc Le Bozec comme Directeur Général pour mener la prochaine phase de croissance stratégique

Nantes, France, 10 mars 2026 – 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) annonce aujourd’hui la transition de Marc Le Bozec de Directeur Général par intérim à Directeur...
March 10, 2026 02:30 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics Confirms Marc Le Bozec as Chief Executive Officer to Lead Next Phase of Strategic Growth

OSE Immunotherapeutics Confirms Marc Le Bozec as Chief Executive Officer to Lead Next Phase of Strategic Growth
March 09, 2026 17:32 ET | Source: Novonesis

Novonesis named a Great Employer to Work For in North Carolina

Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group...
March 09, 2026 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Appoints John Bencich as Chief Financial Officer

AEON Biopharma Appoints John Bencich as Chief Financial Officer
March 09, 2026 09:05 ET | Source: MannKind

MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026

MANNKIND TO PRESENT NEW DATA FROM PEDIATRIC AND ADULT STUDIES OF AFREZZA® AT ATTD 2026
March 09, 2026 08:05 ET | Source: Sangamo Therapeutics, Inc.

Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Sangamo has now submitted the ST-920 preclinical and clinical modules to the FDA for review.